N/A
N=21
Visual Activity Evoked by Infrared in Humans After Dark Adaptation
Age Related Macular Degeneration · Retinitis Pigmentosa · Congenital Stationary Night Blindness · Colorblindness
Bottom Line
View on ClinicalTrials.gov: NCT02909985 ↗Enrolled (actual)
21
Serious AEs
0.0%
Results posted
Dec 2024
Primary outcome: Primary: Visual Perception to Infrared: Mean Minimal Intensity (uW) at Which Participants Could See IR Between 900 - 1400 nm. — 0.671770454; 0.809204; 0.205456012; 0.222247 uW — p=<0.0001
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Tungsten halogen light with narrow bandpass filters (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of New Mexico
- Primary completion
- Aug 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Visual Perception to Infrared: Mean Minimal Intensity (uW) at Which Participants Could See IR Between 900 - 1400 nm. |
0.671770454; 0.809204; 0.205456012; 0.222247; 0.281608408; 0.545299 | <0.0001 sig |
| SECONDARY Description of Color |
12; 4; 3; 0; 0; 1 | — |
Summary
This pilot study will evaluate the visual response to infrared (IR) in humans after dark adaptation. The investigators plan to determine which wavelength and intensity the human eye is most sensitive to in healthy and color-blind participants by using a broad spectrum light source and wavelength-specific IR bandpass filters.
The long-term goal of this research is to better understand the role that IR plays in visual function, and whether this can be manipulated to allow for vision in certain retinal pathologies that result from loss of photoreceptor cells. The investigators central objective is to test the electrophysiologic response to IR in the dark-adapted retinal and visual pathways. The investigator's central hypothesis is that IR evokes a visual response in humans after dark adaptation, and the characteristics of this response suggest transient receptor potential (TRP) channel involvement. The investigators rationale is that a better understanding of how IR impacts vision may allow for an alternative mechanism for vision in a number of diseases that cause blindness from the degradation or loss of function of photoreceptor cells. The investigators will test the investigator's hypothesis with the following Aims:
Aim 1:
Arm 1: To determine the optimal IR wavelength for visual perception in dark-adapted human participants. The investigators hypothesize that the healthy human eye will detect IR irradiation, with a maximum sensitivity at a specific wavelength. Using a broad-spectrum light source with wavelength-specific bandpass filters, the spectral range of visual perception to IR will be evaluated.
Arm 2: To determine the optimal IR wavelength for visual perception in dark-adapted human participants who are colorblind. The investigators hypothesize that the colorblind human eye will detect IR irradiation, with a maximum sensitivity at a specific wavelength. Using a broad-spectrum light source with wavelength-specific bandpass filters, the spectral range of visual perception to IR will be evaluated.
Eligibility Criteria
Inclusion Criteria
- Normal Vision
- Colorblindness
- Age related macular degeneration
- Congenital Stationary Night Blindness
Exclusion Criteria
- Diabetes
- Heart disease
- History of eye injury
- History of eye trauma
- History of eye disease except for those specified in the inclusion criteria
- Pregnant women will also be excluded from Aim 2 and 3
- Persons with allergies to adhesives will be excluded from Aim 2 and 3
- Contact dermatitis
- Documented adverse reaction to dilating drops
- Documented adverse reaction to topical anesthetics
- Vulnerable populations
Data sourced from ClinicalTrials.gov (NCT02909985). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.